Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0460
Abstract: Background Immunotherapy (IT) has evolved as an essential pillar against cancer due to unprecedented successes in several malignancies. However, only 10% of glioblastoma (GBM) patients respond to IT, presumably due to the paucity of tumor-infiltrating…
read more here.
Keywords:
gl261 cells;
gbm;
anti tumor;
tumor immune ... See more keywords